Simplifying Testing, Amplifying Access
SalivaDirect, Inc. (SDI) is advancing the use of saliva-based testing as a readily-deployable, sensitive, patient-friendly option that increases access to affordable and equitable infectious disease testing.
Save the Date
SalivaDirect, Inc. is thrilled to announce that our annual conference for 2025 will be held virtually! Mark your calendars for June 3-6 to hear from top experts in diagnostics on a GLOBAL scale.
Meet Our Conference Speakers
SDI is pleased to introduce the speaker line up for our 4th Annual Conference (now virtual).
Shape the Future of Diagnostics
Join our community of supporters today to be part of making diagnostic testing more accessible for all.
Stay up to date.
Subscribe to Our Newsletter
The SalivaDirect™ test is a cutting-edge, non-invasive COVID-19 diagnostic test that detects SARS-CoV-2 RNA from saliva samples.
The SalivaDirect™ Test for COVID-19 is:
Non-Invasive and Self-Collectible
Saliva collection is non-invasive, reducing patient aversion to testing. It is readily self-collected, which can reduce the risk of viral transmission to healthcare workers.
Flexible and Scalable
The flexible nature of the SalivaDirect™ protocol reduces barriers to entry for labs by allowing them to use their existing reagent and instrument suppliers.
Cost-Efficient
Our test does not require swabs or preservative media in saliva collection devices, reducing the cost of the test kit itself. Utilizing a nucleic acid extraction-free approach reduces the cost of reagents and labor, as well as improves a laboratory’s turnaround time.
Authorized for Emergency Use by the FDA
The SalivaDirect™ protocol for SARS-CoV-2 has been authorized for Emergency Use by the U.S. Food and Drug Administration, ensuring it meets the agency’s rigorous performance standards for in vitro diagnostics. It has also been independently validated in 15+ countries around the globe. We anticipate a submission for De Novo authorization from the U.S. Food and Drug Administration in 2025.
Our Funding Partners
News and Updates
High-Tech Mobile Lab-in-a-Van Will Bring Needed Testing to Underserved Communities
April 24, 2023
New Partnership Between CT, Yale to Expand Saliva-Based COVID Testing at 2 New Haven Locations
January 27, 2022
Saliva-Based COVID-19 Test Developed by Yale Scientists Authorized for Emergency Use by FDA
August 15, 2020
